Oxaliplatin-induced Pulmonary Toxicity: A Rare but Serious Complication

The FOLFOX regimen (oxaliplatin, leucovorin, and 5-fluorouracil) is FDA approved for use in patients with colorectal cancer and other gastrointestinal malignancies. The initial phase III randomized controlled trials that led to FDA approval of oxaliplatin with leucovorin and 5-fluorouracil showed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suthar, Krishna H, Al Mutar, Salwan, Venkatesan, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Radiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188452/
https://www.ncbi.nlm.nih.gov/pubmed/32351861
http://dx.doi.org/10.7759/cureus.7483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188452/
https://www.ncbi.nlm.nih.gov/pubmed/32351861
http://dx.doi.org/10.7759/cureus.7483

Ejemplares similares